CH4 Global’s First Commercial Sale of Asparagopsis Supplement

C​H4 Global™ (CH4), Inc. has announced the first commercial sale and supply of its proprietary Asparagopsis-based product for ruminant animals to reduce agricultural emissions of methane. The initial sale is to CirPro, a leading Australian advanced protein manufacturer and meat processor, for use across its feedlot partners. CH4 Global’s Australia and New Zealand operations will supply product formulated from Asparagopsis seaweed from both marine and tank cultivation.

The long-term multi-million-dollar commitment, with an option to further expand after the initial term, is a substantial step towards CH4 meeting its ambitious global growth plan. “CirPro is excited to partner with CH4 Global for the first commercial supply of Asparagopsis seaweed-supplement in Australia. This marks an important milestone towards the goal of a carbon-neutral beef industry in Australia by systemically reducing, not just offsetting, emissions. It represents a win for the beef industry, a win for Australia, and a win for the planet,” said Roger Smyth, CEO, CirPro.

5-year target of reaching 150 million cattle

CH4 Global’s proprietary formulation is based on Asparagopsis, an ingredient that, when grown and processed to exacting standards, has been proven to reduce enteric methane emissions (burps) in cattle by up to 90% while improving feed efficiency. CH4 Global’s methane-reduction roadmap includes a 5-year target of reaching 150 million cattle — 10% of the world’s total — on all six habitable continents, which will prevent the emission of 1 gigaton of CO₂ equivalent.

Plans for 2023 and 2024 are focused on rapid commercial growth in Australia and New Zealand through Asparagopsis production by CH4’s regional subsidiaries, CH4 Australia and CH4 Aotearoa. Work is also well underway in North America to develop Asparagopsis production capacity there. In 2024 the company will focus on expanding into the remaining habitable continents and the dairy sector to make a global impact on climate change, at scale, with urgency.

“The only way to impact climate change at scale, with urgency, is to approach it as transformation, not solely product innovation. No one-off product innovator will be capable of bending the climate curve any time soon,” said Steve Meller, PhD, CEO and Founder of CH4 Global.

“Scaling exponentially through our growing partner network makes this agreement the tip of an iceberg that will be more fully realized in the next few years,” he said. “A key aspect of this global partnership network is our core principle of working with local and indigenous communities for seaweed-growing partnerships.”

Cassandra Kelly, Senior Advisor to FutureFeed, the holder of the patent on Asparagopsis methane-reduction efficacy, said, “The first commercial sale for CH4 Global was a significant milestone in the commercialization of Asparagopsis. CH4 Global, headquartered in Henderson, Nevada, with subsidiaries in Australia and New Zealand, was one of the first to embrace the world-changing potential of Asparagopsis, and FutureFeed looks forward to the realization of the significant global impact that this incredible technology offers.”